Quarterly Earnings

BitFuFu wins a top FinTech award by making Bitcoin mining accessible. But can its global strategy withstand the industry's volatility and risks?

China's MRO giant ZKH Group returns to profitability, fueled by a surge in customers, AI automation, and an aggressive international expansion strategy.

Brazil's largest holding company announces a historic 11% profit increase, a 59% shareholder return, and massive payouts, all amid high interest rates.

Facing financial headwinds, Lulus is betting big on wholesale. Can new deals with Amazon and Victoria's Secret secure its future in fashion?

Chinese lifestyle group Atour surpasses growth targets with a 35% revenue jump, fueled by hotel expansion and a booming retail business.

Tencent Music posts record profits and a huge dividend, but a shrinking user base and a new policy to hide key metrics leave investors wary.

After a year of major restructuring and a new CEO, Innovative Food Holdings' upcoming earnings call will reveal if its new strategy is paying off.

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

As executives head to a key summit, all eyes are on OPENLANE's plan to navigate a used car market ripe with digital opportunity and economic risk.

How did a top lender achieve record success in a brutal 2025 housing market? By giving millions away, Movement Mortgage presents a new model for profit with purpose.

Cybersecurity firm Telos smashes Q4 estimates, driving its stock up over 21% with a strong forecast amid booming demand for identity and cloud security.

Blockchain firm BTCS is overhauling executive pay to prioritize profitability, a move signaling a strategic shift for the maturing crypto industry.

The body contouring firm faces investor unease over a delayed annual report, even as it points to a sales rebound from a new marketing push.

Silvercrest Asset Management will report its 2025 results on March 17, with investors watching if record AUM growth can overcome rising costs and margin pressure.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

The Joint Corp. posts higher profits through a major franchise pivot, but declining patient visits and sales raise questions about its long-term health.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

As Argan prepares its Q4 results, investors are watching if its record backlog and dual energy strategy can sustain its powerful year-end performance.

The discount giant posts a 106% jump in quarterly profit and outlines aggressive store renovation and expansion plans for 2026 after a stellar year.